HUP0402546A3 - Combination of a pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridine derivative as a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist - Google Patents
Combination of a pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridine derivative as a selective pde4 inhibitor and an adrenergic beta-2 receptor agonistInfo
- Publication number
- HUP0402546A3 HUP0402546A3 HU0402546A HUP0402546A HUP0402546A3 HU P0402546 A3 HUP0402546 A3 HU P0402546A3 HU 0402546 A HU0402546 A HU 0402546A HU P0402546 A HUP0402546 A HU P0402546A HU P0402546 A3 HUP0402546 A3 HU P0402546A3
- Authority
- HU
- Hungary
- Prior art keywords
- triazolo
- pyrazolo
- alpha
- combination
- receptor agonist
- Prior art date
Links
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title 1
- 239000000614 adrenergic beta-2 receptor agonist Substances 0.000 title 1
- 229940124627 adrenergic β2 receptor agonist Drugs 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0129395.0A GB0129395D0 (en) | 2001-12-07 | 2001-12-07 | Pharmaceutical combination |
PCT/IB2002/004922 WO2003047578A1 (en) | 2001-12-07 | 2002-11-22 | Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402546A2 HUP0402546A2 (hu) | 2005-04-28 |
HUP0402546A3 true HUP0402546A3 (en) | 2008-04-28 |
Family
ID=9927247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402546A HUP0402546A3 (en) | 2001-12-07 | 2002-11-22 | Combination of a pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridine derivative as a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
Country Status (33)
Country | Link |
---|---|
US (2) | US20030119862A1 (hu) |
EP (1) | EP1455783A1 (hu) |
JP (1) | JP2005511657A (hu) |
KR (1) | KR20050044699A (hu) |
CN (1) | CN1599609A (hu) |
AP (1) | AP2004003054A0 (hu) |
AR (1) | AR037712A1 (hu) |
AU (1) | AU2002353255A1 (hu) |
BR (1) | BR0214776A (hu) |
CA (1) | CA2468676A1 (hu) |
CO (1) | CO5590899A2 (hu) |
EA (1) | EA200400640A1 (hu) |
EC (1) | ECSP045142A (hu) |
GB (1) | GB0129395D0 (hu) |
HN (1) | HN2002000356A (hu) |
HR (1) | HRP20040515A2 (hu) |
HU (1) | HUP0402546A3 (hu) |
IL (1) | IL162098A0 (hu) |
IS (1) | IS7277A (hu) |
MA (1) | MA27152A1 (hu) |
MX (1) | MXPA04004930A (hu) |
NO (1) | NO20042870L (hu) |
NZ (1) | NZ533030A (hu) |
OA (1) | OA12736A (hu) |
PA (1) | PA8560601A1 (hu) |
PE (1) | PE20031066A1 (hu) |
PL (1) | PL370770A1 (hu) |
SV (1) | SV2004001430A (hu) |
TN (1) | TNSN04102A1 (hu) |
TW (1) | TWI242433B (hu) |
UY (1) | UY27564A1 (hu) |
WO (1) | WO2003047578A1 (hu) |
ZA (1) | ZA200403905B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
DE10360954B3 (de) * | 2003-12-23 | 2005-08-18 | Esparma Gmbh | Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen |
WO2012098495A1 (en) * | 2011-01-19 | 2012-07-26 | Glenmark Pharmaceuticals Sa | Pharmaceutical composition that includes revamilast and a beta-2 agonist |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0837860T3 (da) * | 1995-06-06 | 2002-05-27 | Pfizer | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner |
BR9913152A (pt) * | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
KR100701904B1 (ko) * | 1999-08-21 | 2007-04-02 | 알타나 파마 아게 | Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합 |
-
2001
- 2001-12-07 GB GBGB0129395.0A patent/GB0129395D0/en not_active Ceased
-
2002
- 2002-11-22 JP JP2003548833A patent/JP2005511657A/ja not_active Withdrawn
- 2002-11-22 MX MXPA04004930A patent/MXPA04004930A/es unknown
- 2002-11-22 AP APAP/P/2004/003054A patent/AP2004003054A0/en unknown
- 2002-11-22 IL IL16209802A patent/IL162098A0/xx unknown
- 2002-11-22 EP EP02788275A patent/EP1455783A1/en not_active Withdrawn
- 2002-11-22 EA EA200400640A patent/EA200400640A1/ru unknown
- 2002-11-22 PL PL02370770A patent/PL370770A1/xx not_active Application Discontinuation
- 2002-11-22 BR BR0214776-9A patent/BR0214776A/pt not_active IP Right Cessation
- 2002-11-22 WO PCT/IB2002/004922 patent/WO2003047578A1/en not_active Application Discontinuation
- 2002-11-22 AU AU2002353255A patent/AU2002353255A1/en not_active Abandoned
- 2002-11-22 HU HU0402546A patent/HUP0402546A3/hu unknown
- 2002-11-22 CN CNA028243935A patent/CN1599609A/zh active Pending
- 2002-11-22 NZ NZ533030A patent/NZ533030A/en not_active IP Right Cessation
- 2002-11-22 CA CA002468676A patent/CA2468676A1/en not_active Abandoned
- 2002-11-22 OA OA1200400162A patent/OA12736A/en unknown
- 2002-11-22 KR KR1020047008613A patent/KR20050044699A/ko active IP Right Grant
- 2002-12-03 US US10/308,962 patent/US20030119862A1/en not_active Abandoned
- 2002-12-05 PE PE2002001175A patent/PE20031066A1/es not_active Application Discontinuation
- 2002-12-05 HN HN2002000356A patent/HN2002000356A/es unknown
- 2002-12-05 AR ARP020104719A patent/AR037712A1/es unknown
- 2002-12-05 UY UY27564A patent/UY27564A1/es not_active Application Discontinuation
- 2002-12-06 TW TW091135479A patent/TWI242433B/zh not_active IP Right Cessation
- 2002-12-06 PA PA20028560601A patent/PA8560601A1/es unknown
- 2002-12-06 SV SV2002001430A patent/SV2004001430A/es not_active Application Discontinuation
-
2003
- 2003-12-16 US US10/736,996 patent/US20040167153A1/en not_active Abandoned
-
2004
- 2004-05-20 ZA ZA200403905A patent/ZA200403905B/en unknown
- 2004-05-21 IS IS7277A patent/IS7277A/is unknown
- 2004-06-02 MA MA27712A patent/MA27152A1/fr unknown
- 2004-06-04 TN TNP2004000102A patent/TNSN04102A1/fr unknown
- 2004-06-04 CO CO04052217A patent/CO5590899A2/es not_active Application Discontinuation
- 2004-06-07 HR HR20040515A patent/HRP20040515A2/hr not_active Application Discontinuation
- 2004-06-07 EC EC2004005142A patent/ECSP045142A/es unknown
- 2004-07-06 NO NO20042870A patent/NO20042870L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0301614A3 (en) | Pyrido[2,3-d]pyrimidini and pyrimido[4,5-d]pyrimidini nucleosides | |
IL169335A0 (en) | PYRAZOLO[3,4,-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | |
HUP0500109A3 (en) | Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones | |
IL147752A0 (en) | Imidazo[1,2-a] pyridine and pyrazolo [2,3-a] pyridine derivatives | |
EP1043998A4 (en) | USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLINE DEPENDENT KINASE INHIBITORS | |
GB0209609D0 (en) | Method for the preparation of hydrogenated hydrocarbons | |
WO2000012504A3 (de) | Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-on | |
CA2311483A1 (en) | IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF | |
SI1430056T1 (sl) | Substituirani 2-pirimidinil-6,7,8,9-tetrahidropirimido (1,2-alfa)pirimidin-4-on in 7-pirimidinil-2,3-dihidroimidazo (1,2-alfa)pirimidin-5(1H)on derivati proti nevrodegenerativnim motnjam | |
EP1071684A4 (en) | IMIDAZO [1,2-A] PYRIDINE AS A AGENT FOR BINDING THE PERIPHERAL BENZODIAZEPINE RECEPTOR | |
AU4203500A (en) | Pyrazolopyrimidines as crf antagonists | |
PT1674456E (pt) | Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas | |
SI1315731T1 (en) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives | |
DK0837860T3 (da) | Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner | |
PL349341A1 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives | |
SG79259A1 (en) | Diaza-spiro[3,5]nonane deravatives | |
HU0103075D0 (en) | Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one derivatives and intermediates thereof | |
EE200400078A (et) | Tritsüklilisi 5,6-dihüdro-9H-pürasolo[3,4-c]-1,2,4-triasolo[4,3-alfa]püridiine sisaldavad inhalatsioonikompositsioonid | |
HUP0402546A3 (en) | Combination of a pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridine derivative as a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist | |
PL370565A1 (en) | 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists | |
HUP0301399A3 (en) | Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine | |
PL370067A1 (en) | 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide | |
PL363077A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
AU2003240742A1 (en) | 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors | |
ZA991411B (en) | Substituted imidazo [1,2-A:3,4A']diquinolinylium interleukin-8 receptor antagonist. |